Bonnier Ventures has become a minority owner in the Swedish diagnostics company Elypta. The company focuses on developing cutting-edge technology that uses liquid biopsies to detect early-stage cancer.
Bonnier protects freedom of speech, freedom of press and the free flow of information. We believe in professional journalism with the legal responsibility that entails; this is our cornerstone. Our media stand in safeguard of democracy, equality and fundamental human rights and freedom.